Dabigatran etexilate in a vitamin-K antagonist non responder patient during Heartware HVAD support.
J Card Surg
; 32(2): 166-167, 2017 Feb.
Article
em En
| MEDLINE
| ID: mdl-28097728
ABSTRACT
We report a case of a patient supported with a HeartWare left ventricular assist device for idiopathic cardiomyopathy who was resistance to vitamin-K antagonists three months after implantation. The patient initially started low-molecular-weight heparin therapy and then, after the onset of an ischemic stroke, switched to dabigatran etexilate (DE). The patient had progressive recovery of cardiac function for which the device was explanted. No thrombotic or bleeding events occurred during DE therapy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cuidados Pós-Operatórios
/
Trombose
/
Vitamina K
/
Cardiomiopatia Dilatada
/
Coração Auxiliar
/
Dabigatrana
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
Limite:
Aged
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article